Prokarium Ltd

Showcase Sponsor

Prokarium is a biotechnology company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology. Our oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases, using live attenuated strains of Salmonella enterica combined with innovative genetic technologies. Vaxonella is a strong stimulator of all arms of immunity, as well as reducing costs and time for vaccine manufacture, and enabling distribution to end-users independently of the cold chain. Prokarium is currently developing vaccines for enteric fever, plague and Chlamydia trachomatis, and is based in London, UK.

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071